| Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial 2003 · multiple-dose activated charcoal · Patients with yellow-oleander poisoning | 200 g | 3 days | 201 |
| Effects of oral activated charcoal on hyperphosphatemia and vascular calcification in Chinese patients with stage 3-4 chronic kidney disease 2019 · OAC group (phase 1) · Adults with stage 3–4 chronic kidney disease and normal serum calcium, phosphorus, and PTH levels | 1.8 g | 1 year | 49 |
| Activated charcoal to prevent irinotecan-induced diarrhea in children 2008 · experimental group · children receiving irinotecan as part of chemotherapy; ages and diagnoses not specified | 750 mg | — | 10 |
| Efficacy of antibiotherapy for treating flatus incontinence associated with small intestinal bacterial overgrowth: A pilot randomized trial 2017 · SC (simethicone and activated charcoal) · Adults over 18 with flatus incontinence and a positive glucose breath test for small intestinal bacterial overgrowth | 420 mg | 10 days | 8 |
| Compliance for single and multiple dose regimens of superactivated charcoal: a prospective study of patients in a clinical trial 2007 · SDAC · Patients admitted to hospitals in Sri Lanka after acute self-poisoning | 50 g | 1 day | 559 |
| Compliance for single and multiple dose regimens of superactivated charcoal: a prospective study of patients in a clinical trial 2007 · MDAC · Patients admitted to hospitals in Sri Lanka after acute self-poisoning | 300 g | 1 day | 544 |
| Comparison of the palatabilities of standard and superactivated charcoal in toxic ingestions: a randomized trial 1999 · CharcoAid G (CA) · Alert adults with known or suspected potentially toxic ingestions requiring activated charcoal | 60 g | 1 day | 31 |
| Comparison of the palatabilities of standard and superactivated charcoal in toxic ingestions: a randomized trial 1999 · LiquiChar (LC) · Alert adults with known or suspected potentially toxic ingestions requiring activated charcoal | 60 g | 1 day | 29 |
| Adverse effects of superactivated charcoal administered to healthy volunteers 2002 · superactivated charcoal group · healthy adult volunteers | 75 g | 1 day | 24 |
| Oral activated charcoal in patients with uremic pruritus 1995 · activated powdered charcoal · 23 chronic uremic patients on maintenance hemodialysis with severe pruritus | 6 g | — | 23 |
| A STUDY ON THE HAEMODYNAMIC INTERACTIONS BETWEEN ACTIVATED CHARCOAL AND PROPRANOLOL/ATENOLOL IN NORMAL HUMAN SUBJECTS 1999 · activated charcoal with propranolol · 12 normal adult male volunteers | 15 g | 1 day | — |
| A STUDY ON THE HAEMODYNAMIC INTERACTIONS BETWEEN ACTIVATED CHARCOAL AND PROPRANOLOL/ATENOLOL IN NORMAL HUMAN SUBJECTS 1999 · activated charcoal with atenolol · 12 normal adult male volunteers | 15 g | 1 day | — |
| Effects of Increased Blood Flow Rate and Oral Activated Charcoal on the Severity of Uremic Pruritus: A Randomized Crossover Clinical Trial 2023 · Daily administration of a charcoal suspension · Hemodialysis patients with uremic pruritus | 6 g | 2 weeks | — |
| Effects of Increased Blood Flow Rate and Oral Activated Charcoal on the Severity of Uremic Pruritus: A Randomized Crossover Clinical Trial 2023 · Concurrent use of increased pumping speed and oral administration of the charcoal suspension · Hemodialysis patients with uremic pruritus | 6 g | 2 weeks | — |
| Efficacy of novel activated bamboo charcoal in reducing uremic toxins and enhancing kidney function in chronic kidney disease patients: a pilot randomized controlled trial 2025 · ABC-treatment group · Adults with stage 3 chronic kidney disease; mean age 65.9 years, 83.3% male | 12 g | 90 days | 12 |
| The study of in vitro-in vivo correlation: pharmacokinetics and pharmacodynamics of albuterol dry powder inhalers 2005 · Activated-charcoal pretreatment · Healthy volunteers and people with asthma; ages not reported, six males and six females in each group | 560 mg | 1 day | 24 |
| Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization 2002 · NEBC · 12 healthy volunteers | 25 g | 1 day | 12 |
| A Colon-Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects 2021 · DAV132 coadministered with warfarin or clonazepam · healthy volunteers; 18 in the warfarin substudy and 24 in the clonazepam substudy | 7.5 g | 1 day | 42 |
| A Colon-Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects 2021 · DAV132 administered 1 hour before warfarin or clonazepam · healthy volunteers; 18 in the warfarin substudy and 24 in the clonazepam substudy | 7.5 g | 1 day | 42 |
| Bioequivalence studies of inhaled indacaterol maleate in healthy Chinese volunteers under gastrointestinal non-blocking or blocking with concomitant charcoal administration 2020 · Charcoal-block subjects · Healthy volunteers; age and sex not stated | 9 g | 1 day | 36 |
| Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects 2019 · SCA concomitant regimens (parts 1 and 2; timing varied) · Healthy Japanese men aged 20–45 years | 6 g | 2 days | 34 |
| Efficacy of superactivated charcoal administered late (3 hours) after acetaminophen overdose 2003 · SAC group · Healthy adult volunteers | 75 g | 1 day | 22 |
| Protection of the Human Gut Microbiome From Antibiotics 2018 · MXF + DAV132 · Healthy adult men and women older than 18 years | 15.3 g | 7 days | 14 |
| Effect of activated charcoal in reducing paracetamol absorption at a supra-therapeutic dose 2010 · Experimental arm · 12 healthy male volunteers | 50 g | 1 day | 12 |
| Effect of anticholinergic drugs on the efficacy of activated charcoal 2004 · activated charcoal alone · 10 healthy volunteers | 50 g | 1 day | 10 |
| Effect of anticholinergic drugs on the efficacy of activated charcoal 2004 · activated charcoal with atropine · 10 healthy volunteers | 50 g | 1 day | 10 |
| Simulated acetaminophen overdose: pharmacokinetics and effectiveness of activated charcoal 1991 · 30 g activated charcoal 15 minutes after acetaminophen · Healthy adult men aged 21–39 years | 30 g | 1 day | 10 |
| Simulated acetaminophen overdose: pharmacokinetics and effectiveness of activated charcoal 1991 · 30 g activated charcoal 30 minutes after acetaminophen · Healthy adult men aged 21–39 years | 30 g | 1 day | 10 |
| Simulated acetaminophen overdose: pharmacokinetics and effectiveness of activated charcoal 1991 · 30 g activated charcoal 120 minutes after acetaminophen · Healthy adult men aged 21–39 years | 30 g | 1 day | 10 |
| Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram 1999 · activated charcoal alone · Nine healthy volunteers; age and sex not specified | 25 g | 1 day | 9 |
| Gastric decontamination performed 5 min after the ingestion of temazepam, verapamil and moclobemide: charcoal is superior to lavage 2000 · activated charcoal · Nine healthy volunteers; age and sex not reported | 25 g | 1 day | 9 |
| Efficacy of activated charcoal versus gastric lavage half an hour after ingestion of moclobemide, temazepam, and verapamil 2000 · activated charcoal · Nine healthy volunteers | 25 g | 1 day | 9 |
| Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs 2001 · 25 g activated charcoal as a suspension · 9 healthy subjects | 25 g | 1 day | 9 |
| Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs 2001 · 25 g activated charcoal as a suspension followed by whole-bowel irrigation with polyethylene glycol (PEG) electrolyte lavage solution · 9 healthy subjects | 25 g | 1 day | 9 |
| Effect of delayed activated charcoal on acetaminophen concentration after simulated overdose of oxycodone and acetaminophen 2009 · activated charcoal at 1 h · Nine healthy human volunteers undergoing simulated combined oral overdose of acetaminophen and oxycodone | 50 g | 1 day | 9 |
| Effect of delayed activated charcoal on acetaminophen concentration after simulated overdose of oxycodone and acetaminophen 2009 · activated charcoal at 2 h · Nine healthy human volunteers undergoing simulated combined oral overdose of acetaminophen and oxycodone | 50 g | 1 day | 9 |
| Effect of delayed activated charcoal on acetaminophen concentration after simulated overdose of oxycodone and acetaminophen 2009 · activated charcoal at 3 h · Nine healthy human volunteers undergoing simulated combined oral overdose of acetaminophen and oxycodone | 50 g | 1 day | 9 |
| Treatment of cholestasis of pregnancy with peroral activated charcoal. A preliminary study 1994 · Activated peroral charcoal · Women with cholestasis of pregnancy | 150 g | 8 days | 9 |
| Comparative antidotal efficacy of activated charcoal tablets, capsules and suspension in healthy volunteers 1990 · activated charcoal suspension · Healthy volunteers; age and sex not specified. | 5 g | 1 day | 8 |
| Drug adsorption efficacy and palatability of a novel charcoal cookie formulation 2010 · charcoal cookies · Eight healthy adults, five men and three women, mean age 23.4 years | 7.2 g | 1 day | 8 |
| Drug adsorption efficacy and palatability of a novel charcoal cookie formulation 2010 · aqueous activated charcoal suspension · Eight healthy adults, five men and three women, mean age 23.4 years | 7.2 g | 1 day | 8 |
| Protection of the Human Gut Microbiome From Antibiotics 2018 · DAV132 alone · Healthy adult men and women older than 18 years | 15.3 g | 7 days | 8 |
| The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration 1996 · Second group · healthy volunteers | 25 g | 1 day | 8 |
| The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration 1996 · Third group · healthy volunteers | 25 g | 1 day | 8 |
| The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration 1996 · Fourth group · healthy volunteers | 25 g | 1 day | 8 |
| Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration 1997 · Activated charcoal administered immediately after amlodipine · Healthy volunteers | 25 g | 1 day | 8 |
| Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration 1997 · Activated charcoal administered 2 h after amlodipine · Healthy volunteers | 25 g | 1 day | 8 |
| Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration 1997 · Activated charcoal administered 6 h after amlodipine · Healthy volunteers | 25 g | 1 day | 8 |
| Randomized controlled study on the use of multiple-dose activated charcoal in patients with supratherapeutic phenytoin levels 2012 · multiple-dose activated charcoal (MDAC) · Adults older than 18, all male, with serum phenytoin levels greater than 30 mg/L upon presentation; nonpregnant and able to tolerate activated charcoal by mouth | 300 g | — | 7 |
| The effect of activated charcoal on the absorption and elimination of astemizole 1994 · multiple-dose activated charcoal group · Healthy volunteers; age and sex not reported | 24 g | 8 days | 7 |
| Acceleration of body clearance of diethylCarbamazine by oral activated charcoal 2000 · 7.5 g activated charcoal · Six healthy volunteers; age and sex not specified | 7.5 g | 1 day | 6 |
| Acceleration of body clearance of diethylCarbamazine by oral activated charcoal 2000 · 15 g activated charcoal · Six healthy volunteers; age and sex not specified | 15 g | 1 day | 6 |
| Prevention of chloroquine absorption by activated charcoal 1992 · Activated charcoal group · Healthy volunteers; age and sex not reported | 25 g | 1 day | 6 |
| Effect of activated charcoal on the absorption of amiodarone 1991 · Charcoal administered simultaneously with amiodarone · Healthy volunteers; age and sex not reported | 25 g | 1 day | 6 |
| Effect of activated charcoal on the absorption of amiodarone 1991 · Charcoal administered 1.5 hours after amiodarone · Healthy volunteers; age and sex not reported | 25 g | 1 day | 6 |
| The adsorption of salicylates by a milk chocolate-charcoal mixture 1991 · Milk chocolate-charcoal mixture · Six healthy adult volunteers; sex and age range not reported; no stated medical condition | 10 g | 1 day | 6 |
| The adsorption of salicylates by a milk chocolate-charcoal mixture 1991 · SuperChar Liquid · Six healthy adult volunteers; sex and age range not reported; no stated medical condition | 10 g | 1 day | 6 |
| The adsorption of salicylates by a milk chocolate-charcoal mixture 1991 · Actidose Aqua activated charcoal · Six healthy adult volunteers; sex and age range not reported; no stated medical condition | 10 g | 1 day | 6 |
| Bioequivalence studies of inhaled indacaterol maleate in healthy Chinese volunteers under gastrointestinal non-blocking or blocking with concomitant charcoal administration 2020 · Pilot study: charcoal-based regimen · Six healthy subjects; age and sex not stated | 9 g | 1 day | 6 |
| Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal 1993 · ipecac-charcoal · Six healthy volunteer men | 50 g | 1 day | 6 |
| Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study 2023 · Part IV, cohort 1: activated charcoal 60 g once daily · Healthy men aged 18–45 years of sub-Saharan origin | 60 g | 7 days | 3 |
| Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study 2023 · Part IV, cohort 2: activated charcoal 20 g three times daily · Healthy men aged 18–45 years of sub-Saharan origin | 60 g | 7 days | 3 |
| Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers 2010 · 50 g activated charcoal (control) · Healthy human volunteers given paracetamol in a simulated overdose study; age and sex not reported | 50 g | 1 day | — |
| Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers 2010 · 25 g activated charcoal · Healthy human volunteers given paracetamol in a simulated overdose study; age and sex not reported | 25 g | 1 day | — |
| Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers 2010 · 5 g activated charcoal · Healthy human volunteers given paracetamol in a simulated overdose study; age and sex not reported | 5 g | 1 day | — |
| Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate 2010 · arm 2, receiving i.v. AS and oral AC simultaneously · Healthy adults aged 21–45 years, malaria-negative, not pregnant, and with haemoglobin >11 g/dl | 100 g | 1 day | — |
| Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate 2010 · arm 3, receiving i.v. AS and oral AC 1 h later · Healthy adults aged 21–45 years, malaria-negative, not pregnant, and with haemoglobin >11 g/dl | 100 g | 1 day | — |
| Effect of activated charcoal on frusemide induced diuresis: a human class experiment for medical students 1990 · 40 mg frusemide and 8 g activated charcoal taken together · medical students; age and sex not reported | 8 g | 1 day | — |
| Effect of activated charcoal on frusemide induced diuresis: a human class experiment for medical students 1990 · 40 mg frusemide and 8 g activated charcoal taken after different time intervals · medical students; age and sex not reported | 8 g | 1 day | — |
| Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study 2023 · Part I cohorts receiving once-daily activated charcoal (except cohorts 1 and 9) · Healthy men aged 18–45 years of sub-Saharan origin | 60 g | 7 days | — |
| Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers 2017 · Healthy volunteers receiving activated charcoal · Healthy adult volunteers; age and sex not specified | 20 g | 1 day | 12 |
| Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil 1997 · Conventional verapamil with activated charcoal immediately afterwards · Healthy volunteers; age and sex not reported | 25 g | 1 day | 9 |
| Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil 1997 · Conventional verapamil with charcoal 2 h later · Healthy volunteers; age and sex not reported | 25 g | 1 day | 9 |
| Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil 1997 · Slow-release verapamil with activated charcoal immediately afterwards · Healthy volunteers; age and sex not reported | 25 g | 1 day | 8 |
| Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil 1997 · Slow-release verapamil with charcoal 2 h later · Healthy volunteers; age and sex not reported | 25 g | 1 day | 8 |
| Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil 1997 · Slow-release verapamil with charcoal 4 h later · Healthy volunteers; age and sex not reported | 25 g | 1 day | 8 |
| The comparative efficacy of various multiple-dose activated charcoal regimens 1992 · 12.5 gm every hour · Five healthy adult volunteers | 12.5 g | 1 day | 5 |
| The comparative efficacy of various multiple-dose activated charcoal regimens 1992 · 25 gm every 2 hours · Five healthy adult volunteers | 12.5 g | 1 day | 5 |
| The comparative efficacy of various multiple-dose activated charcoal regimens 1992 · 50 gm every 4 hours · Five healthy adult volunteers | 12.5 g | 1 day | 5 |